Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statementDavid Taïeb, Karel Pacák, Joakim Crona et al.|Nature Reviews Endocrinology|2023Cited by 95
Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohortChristina Pamporaki, Graeme Eisenhofer, Annika M.A. Berends et al.|The Lancet Digital Health|2023Cited by 70
Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paragangliomaChristina Pamporaki, Graeme Eisenhofer, Tamara Prodanov et al.|European Journal of Cancer|2022Cited by 43
Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramineSusan Richter, Graeme Eisenhofer, Bei Qiu et al.|Zurich Open Repository and Archive (University of Zurich)|2022Cited by 37
Recurrent Disease in Patients With Sporadic Pheochromocytoma and ParagangliomaMinghao Li, Christina Pamporaki, Tamara Prodanov et al.|The Journal of Clinical Endocrinology & Metabolism|2022Cited by 36